E-Mail
Memphis, Tenn. (May 11, 2021) - The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million.
Since its launch in 2018, CTN2 has brought more than 200 clinical trial opportunities to the university and the citizens of Tennessee. Steven R. Goodman, PhD, vice chancellor for Research at UTHSC, who led the creation of CTN2, lauded the tremendous success of the nonprofit that enables clinical research faculty across all the UTHSC campuses, who are affiliated with hospitals, to effectively respond to opportunities for clinical trials with pharmaceutical, biotech, and medical device industry partners.
E-Mail
DALLAS, May 10, 2021 In a small study, researchers found college athletes who contracted COVID-19 rarely had cardiac complications. Most had mild COVID symptoms that did not require treatment, and in a small percentage of those with abnormal cardiac testing, there was no evidence of heart damage on special imaging tests. All athletes returned to sports without any health concerns, according to new research published today in the American Heart Association’s flagship journal
Circulation.
In spring 2020, concerns about heart damage, especially inflammation, among athletes with COVID-19 led to recommendations for cardiac screening based on symptom severity before resuming training and competition. The preferred diagnostic test for heart inflammation is an MRI of the heart, or cardiac magnetic resonance imaging. The American College of Cardiology’s Sports & Exercise Cardiology Council’s standard recommendations, issued in May 2020, do not advise cardiac MRI as an ini
Cardiac complications found to be rare in college athletes who contracted COVID-19
In a small study, researchers found college athletes who contracted COVID-19 rarely had cardiac complications. Most had mild COVID symptoms that did not require treatment, and in a small percentage of those with abnormal cardiac testing, there was no evidence of heart damage on special imaging tests. All athletes returned to sports without any health concerns, according to new research published today in the American Heart Association s flagship journal
Circulation.
In spring 2020, concerns about heart damage, especially inflammation, among athletes with COVID-19 led to recommendations for cardiac screening based on symptom severity before resuming training and competition. The preferred diagnostic test for heart inflammation is an MRI of the heart, or cardiac magnetic resonance imaging. The American College of Cardiology s Sports & Exercise Cardiology Council s standard recommendations, issued in
Search continues for man suspected of firing shots at officers, 3 others in custody
MPD officer, ATF agent shot while searching for carjacking suspects By Janice Broach | May 7, 2021 at 9:39 PM CDT - Updated May 7 at 10:25 PM
MEMPHIS, Tenn. (WMC) - The two officers who were taken to Regional One Medical Center after being shot Friday afternoon are in non-critical condition.
Police have three suspects in custody but one is still on the run.
”It’s crazy,” said Edwin Moore.
Moore and his neighbors saw police everywhere near the Medical District on multiple streets after officers from the violent crimes unit were shot by suspects.